JPWO2022210784A1 - - Google Patents
Info
- Publication number
- JPWO2022210784A1 JPWO2022210784A1 JP2022546133A JP2022546133A JPWO2022210784A1 JP WO2022210784 A1 JPWO2022210784 A1 JP WO2022210784A1 JP 2022546133 A JP2022546133 A JP 2022546133A JP 2022546133 A JP2022546133 A JP 2022546133A JP WO2022210784 A1 JPWO2022210784 A1 JP WO2022210784A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022178888A JP7273235B2 (ja) | 2021-03-30 | 2022-11-08 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021057713 | 2021-03-30 | ||
| JP2021057713 | 2021-03-30 | ||
| PCT/JP2022/015691 WO2022210784A1 (ja) | 2021-03-30 | 2022-03-29 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178888A Division JP7273235B2 (ja) | 2021-03-30 | 2022-11-08 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022210784A1 true JPWO2022210784A1 (https=) | 2022-10-06 |
| JP7175431B1 JP7175431B1 (ja) | 2022-11-18 |
| JPWO2022210784A5 JPWO2022210784A5 (https=) | 2023-02-28 |
Family
ID=83459508
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022546133A Active JP7175431B1 (ja) | 2021-03-30 | 2022-03-29 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
| JP2022178888A Active JP7273235B2 (ja) | 2021-03-30 | 2022-11-08 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
| JP2023073689A Pending JP2023099107A (ja) | 2021-03-30 | 2023-04-27 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178888A Active JP7273235B2 (ja) | 2021-03-30 | 2022-11-08 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
| JP2023073689A Pending JP2023099107A (ja) | 2021-03-30 | 2023-04-27 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12564553B2 (https=) |
| EP (1) | EP4316485A4 (https=) |
| JP (3) | JP7175431B1 (https=) |
| KR (1) | KR20230163502A (https=) |
| CN (1) | CN117120048A (https=) |
| AU (1) | AU2022250028A1 (https=) |
| BR (1) | BR112023019820A2 (https=) |
| CA (1) | CA3215750A1 (https=) |
| MX (1) | MX2023011649A (https=) |
| WO (1) | WO2022210784A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024019118A1 (https=) | 2022-07-20 | 2024-01-25 | ||
| WO2025206172A1 (ja) * | 2024-03-28 | 2025-10-02 | 千寿製薬株式会社 | 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61164725A (ja) | 1985-01-11 | 1986-07-25 | Inoue Japax Res Inc | ワイヤ電極案内 |
| JPH07304663A (ja) * | 1994-03-18 | 1995-11-21 | Senju Pharmaceut Co Ltd | 眼圧降下用点眼剤 |
| ATE166227T1 (de) | 1994-03-18 | 1998-06-15 | Senju Pharma Co | Sarpogrelat enthaltende opthalmologische zubereitungen zur senkung des intraokularen druckes |
| JP3402195B2 (ja) * | 1997-05-14 | 2003-04-28 | 千寿製薬株式会社 | 再分散性の良い水性懸濁液剤 |
| EP0995435B1 (en) * | 1997-05-14 | 2007-04-25 | Senju Pharmaceutical Co., Ltd. | Aqueous suspension preparations with excellent redispersibility |
| JP4754566B2 (ja) | 2005-07-22 | 2011-08-24 | 持田製薬株式会社 | 新規なヘテロシクリデンアセトアミド誘導体 |
| WO2008123396A1 (ja) | 2007-03-29 | 2008-10-16 | Santen Pharmaceutical Co., Ltd. | フルオロメトロンを含有する懸濁型点眼剤 |
| ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
| JP6230743B1 (ja) * | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| CN112409191A (zh) | 2019-08-23 | 2021-02-26 | 持田制药株式会社 | 光学活性的氨基醇的制备方法 |
| KR102656181B1 (ko) * | 2019-08-27 | 2024-04-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물 |
| JP7419728B2 (ja) | 2019-09-27 | 2024-01-23 | ブラザー工業株式会社 | 通信装置と通信装置のためのコンピュータプログラム |
| CA3156484A1 (en) | 2019-10-04 | 2021-04-08 | Senju Pharmaceutical Co., Ltd. | PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE |
-
2022
- 2022-03-29 CN CN202280026310.3A patent/CN117120048A/zh active Pending
- 2022-03-29 US US18/553,141 patent/US12564553B2/en active Active
- 2022-03-29 EP EP22780995.1A patent/EP4316485A4/en active Pending
- 2022-03-29 BR BR112023019820A patent/BR112023019820A2/pt unknown
- 2022-03-29 AU AU2022250028A patent/AU2022250028A1/en active Pending
- 2022-03-29 WO PCT/JP2022/015691 patent/WO2022210784A1/ja not_active Ceased
- 2022-03-29 KR KR1020237037161A patent/KR20230163502A/ko active Pending
- 2022-03-29 JP JP2022546133A patent/JP7175431B1/ja active Active
- 2022-03-29 CA CA3215750A patent/CA3215750A1/en active Pending
- 2022-03-29 MX MX2023011649A patent/MX2023011649A/es unknown
- 2022-11-08 JP JP2022178888A patent/JP7273235B2/ja active Active
-
2023
- 2023-04-27 JP JP2023073689A patent/JP2023099107A/ja active Pending
-
2025
- 2025-01-03 US US19/009,331 patent/US12527740B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US12527740B2 (en) | 2026-01-20 |
| EP4316485A1 (en) | 2024-02-07 |
| JP2023099107A (ja) | 2023-07-11 |
| AU2022250028A1 (en) | 2023-11-16 |
| MX2023011649A (es) | 2023-10-11 |
| BR112023019820A2 (pt) | 2023-11-07 |
| US12564553B2 (en) | 2026-03-03 |
| JP7175431B1 (ja) | 2022-11-18 |
| JP7273235B2 (ja) | 2023-05-12 |
| US20240180827A1 (en) | 2024-06-06 |
| KR20230163502A (ko) | 2023-11-30 |
| EP4316485A4 (en) | 2025-03-26 |
| CN117120048A (zh) | 2023-11-24 |
| WO2022210784A1 (ja) | 2022-10-06 |
| US20250134808A1 (en) | 2025-05-01 |
| JP2023011898A (ja) | 2023-01-24 |
| CA3215750A1 (en) | 2022-10-06 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220728 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220728 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220728 |
|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20220810 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220829 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221012 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221020 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221102 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221108 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7175431 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D04 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |